⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
ATIP / AT2 Signaling and Amyloid Pathology
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-28 — Is amyloid beta peptide a driver of inflammaging?: cross-connection with amyloid-beta-inflammaging: Both pages address amyloid pathology outside the pure AD-biomarker frame; the Aβ-inflammaging reframe complements the ATIP/AT2 signaling angle by locating Aβ in a chronic low-grade neuroinflammatory context rather than as a lesion marker. (novelty: 3)
- 2026-09-25 — Type 2 Angiotensin II receptor (AT2R) deficiency exacerbates cardiac senescence and fibrosis in aging mice.: cross-connection with at2r-cardiac-aging: Both invoke AT2 signaling as an aging-relevant lever, but in distinct tissues (cardiac senescence/fibrosis vs. brain amyloid pathology) — worth tracking together as the AT2R healthspan story develops across organs. (novelty: 3)
- 2026-08-28 — Senescent cells maintain viability through adhesion-dependent fragmentation that promotes debris deposition.: cross-connection with inflammaging: SCAF rupture is proposed to deposit amyloid-like material and neurodegeneration-linked proteins extracellularly, linking a senescence-fragmentation mechanism to amyloid pathology substrates. (novelty: 4)